Would be great to increase the number of Genomic ETF’s on trading 212.
What are the thoughts on current T212 options?
Would be great to increase the number of Genomic ETF’s on trading 212.
What are the thoughts on current T212 options?
Having done too much searching but iShares NASDAQ Biotechnology (BTEE) is the best alternative to ARKG as far as I’m aware
If you follow the links from underlying ARKG stocks here ‘ FinKi - Project Noah - ARK. then the recurring ETFs holding ‘similar’ stocks appear to be iShares Healthcare, L&G Healthcare Breakthrough, GlobalX Telemedicine and BTEE you mention.